Conservative Management of Breast Cancer: Research at the Joint Center for Radiation Therapy, Harvard Medical School
Anthony Abner M.D.,
Jay Harris M.D.,
Corresponding Author
Anthony Abner M.D.
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA
Address correspondence and reprint requests to: Anthony Abner, M.D., 330 Brookline Ave., Boston, MA 02215Search for more papers by this authorJay Harris M.D.
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA
Search for more papers by this authorAnthony Abner M.D.,
Jay Harris M.D.,
Corresponding Author
Anthony Abner M.D.
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA
Address correspondence and reprint requests to: Anthony Abner, M.D., 330 Brookline Ave., Boston, MA 02215Search for more papers by this authorJay Harris M.D.
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA
Search for more papers by this authorFirst published: 30 January 2007
Abstract
Abstract: The use of conservative surgery and radiation therapy for the management of early stage breast cancer is now well established, but significant questions remain. This paper summarizes recent studies of the Joint Center for Radiation Therapy, a Harvard Medical School study in the treatment of ductal cancer in situ, the sequencing of chemotherapy and radiation, the issue of margin status, and the use of excision alone.
REFERENCES
- 1 Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988; 318(14): 898–903.
- 2 Recht A. Treatment of in situ ductal breast cancer. Front Radiat Ther Oncol 1993; 27: 52–61.
- 3 Lagios M. Ductal carcinoma in situ: pathology and treatment. Surg Clin North Am 1990; 70: 853–71.
- 4
Lagios M,
Margolin F,
Westdahy P,
Rose M.
Mammo-graphically detected duct carcinoma in situ frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.
Cancer
1989; 63: 618–24.
10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- 5
Silverstein MJ,
Lagios MD,
Craig PH, et al.
A prognostic index for ductal carcinoma in situ of the breast.
Cancer
1996; 77(11): 2267–74.
10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V PubMed Web of Science® Google Scholar
- 6
Schnitt SJ,
Harris JR,
Smith BL.
Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet
Cancer
1996; 77(11): 2189–92.
10.1002/(SICI)1097-0142(19960601)77:11<2189::AID-CNCR1>3.0.CO;2-L PubMed Web of Science® Google Scholar
- 7 Recht A, Harris JR, Come SE. Sequencing of irradiation and chemotherapy for early-stage breast cancer. Oncology 1994; 8(3): 19–28; discussion 28, 31–2, 37.
- 8 McCormick B, Hakes T, Yahalom J, Kinne D, Norton L. Breast-conserving surgery and radiation: the delay of primary radiation after adjuvant chemotherapy does not influence local control (Meeting Abstract). Proc Annu Meet Am Soc Clin Oncol 1992; 11: A47.
- 9 McCormick B, Begg CB, Norton L, Yao TJ, Kinne D. Timing of radiotherapy in the treatment of early-stage breast cancer. J Clin Oncol 1993; 11(1): 191–93.
- 10 Buchholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation on the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 1993; 26(1): 23–35.
- 11 Abner AL, Recht A, Vicini FA, et al. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1991; 21(2): 331–38.
- 12 Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996; 334(21): 1356–61.
- 13 Solin LJ, Fowble BL, Schultz DJ, Goodman RL. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 1991; 21(2): 279–87.
- 14 Schmidt-Ullrich R, Wazer D, Tercilla O, et al. Tumor margin assessment as a guide to optimal surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys 1989; 17: 733–38.
- 15 Frazier T, Wong R, Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg 1989; 124: 37–38.
- 16 Gage I, Nixon N, Schnitt S, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast conserving therapy. Int J Rad Onc Biol Phys 1995; 32(Suppl): 138.
- 17
Schnitt SJ,
Hayman J,
Gelman R, et al.
A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer.
Cancer
1996; 77(6): 1094–100.
10.1002/(SICI)1097-0142(19960315)77:6<1094::AID-CNCR14>3.0.CO;2-X PubMed Web of Science® Google Scholar
- 18
Hayman J,
Hillner B,
Harris J,
Weeks J.
The cost effectiveness of routine irradiation therapy (RT) following conservative surgery (CS) for early stage breast cancer.
Int J Rad Onc Biol Phys
1996; 36(Suppl): 216.
10.1016/S0360-3016(97)85457-0 Google Scholar
